Comprehensive Medical Weight Loss
Unless you live under a rock, by now you’ve heard of semaglutide – the weekly weight loss injection. But how does semaglutide stack up against the first-ever weight loss medication, phentermine? History of Semaglutide and Phentermine Semaglutide was developed by…
Contrave is one of our new anti-obesity medications, or “AOMs” approved for chronic weight management in 2014. As the years have gone by, we have accumulated a lot of clinical experience with Contrave for weight loss. This article will review…
Phentermine was originally approved by the FDA for weight loss in the 1950’s. In those days, few people had obesity, and obesity was thought to be the result of simple dietary indiscretion. Phentermine in those days was studied and approved…
Shortly after recommending approval of Qnexa (Phentermine / Topiramate), the FDA advisory panel this week also voted to approve Arena Pharmaceuticals weight loss drug, Lorgess (Lorcacerin). This medication has been in clinical trials over the past several years and works…
Today the FDA announced that instead of reviewing Qnexa, the new weight loss drug by Vivus, combining Phentermine and Topiramate, they are pushing back the review date by 3 months to July 17th, 2012, to allow time to review all…
On February 22nd, 2012, the Advisory Committee to the FDA met to review a new weight loss drug, Qnexa. This drug is a combination of Phentermine and Topiramate, and the combination yields substantially better weight loss than Phentermine alone, even…
The FDA is again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take the drug. California-based pharmaceutical company Vivus…
Qnexa is a drug in development by California company Vivus. In a new study published in the Lancet, Qnexa helped individuals not only lose an average of 22 pounds during the year, but also see improvements in blood pressure, cholesterol…
